DePrince Race & Zollo Inc (DRZ)’s Johnson & Johnson JNJ Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.8M	Sell	260,858 -630	-0.2%	-$147K	1.2%	17
2025 Q4	$54.1M	Buy	261,488 +3,727	+1%	+$737K	1.04%	20
2025 Q3	$47.8M	Sell	257,761 -5,180	-2%	-$887K	0.96%	26
2025 Q2	$40.2M	Sell	262,941 -3,430	-1%	-$527K	0.83%	34
2025 Q1	$44.2M	Sell	266,371 -58,941	-18%	-$9.22M	0.92%	30
2024 Q4	$47M	Buy	325,312 +364	+0.1%	+$56.4K	0.93%	28
2024 Q3	$52.7M	Buy	324,948 +23,067	+8%	+$3.68M	1.01%	26
2024 Q2	$44.1M	Sell	301,881 -3,696	-1%	-$550K	0.98%	27
2024 Q1	$48.3M	Buy	305,577 +12,138	+4%	+$1.93M	1.04%	22
2023 Q4	$46M	Sell	293,439 -3,202	-1%	-$491K	1.04%	23
2023 Q3	$46.2M	Sell	296,641 -2,236	-0.7%	-$369K	1.12%	18
2023 Q2	$49.5M	Sell	298,877 -7,082	-2%	-$1.14M	1.14%	18
2023 Q1	$47.4M	Buy	305,959 +32,126	+12%	+$5.19M	1.1%	17
2022 Q4	$48.4M	Sell	273,833 -33,006	-11%	-$5.7M	1.11%	17
2022 Q3	$50.1M	Buy	306,839 +60,476	+25%	+$10.2M	1.28%	6
2022 Q2	$43.7M	Sell	246,363 -720	-0.3%	-$128K	1.01%	28
2022 Q1	$43.8M	Sell	247,083 -542	-0.2%	-$92.2K	0.85%	35
2021 Q4	$42.4M	Buy	247,625 +68,559	+38%	+$11.2M	1.08%	10
2021 Q3	$28.9M	Sell	179,066 -3,092	-2%	-$528K	0.77%	42
2021 Q2	$30M	Buy	182,158 +2,205	+1%	+$365K	0.76%	40
2021 Q1	$29.6M	Buy	179,953 +55,638	+45%	+$9M	0.8%	34
2020 Q4	$19.6M	Buy	124,315 +15,323	+14%	+$2.26M	0.62%	67
2020 Q3	$16.2M	Buy	108,992 +2,071	+2%	+$306K	0.61%	67
2020 Q2	$15M	Sell	106,921 -34,683	-24%	-$5.05M	0.58%	76
2020 Q1	$18.6M	Buy	141,604 +460	+0.3%	+$65.3K	0.85%	34
2019 Q4	$20.6M	Sell	141,144 -12,681	-8%	-$1.72M	0.63%	64
2019 Q3	$19.9M	Buy	153,825 +9,146	+6%	+$1.2M	0.58%	83
2019 Q2	$20.2M	Buy	144,679 +3,143	+2%	+$435K	0.56%	81
2019 Q1	$19.8M	Sell	141,536 -1,450	-1%	-$194K	0.54%	85
2018 Q4	$18.5M	Sell	142,986 -20,084	-12%	-$2.8M	0.53%	86
2018 Q3	$22.5M	Sell	163,070 -1,480	-0.9%	-$197K	0.5%	85
2018 Q2	$20M	Buy	164,550 +10,991	+7%	+$1.37M	0.46%	97
2018 Q1	$19.7M	Buy	153,559 +9,280	+6%	+$1.25M	0.46%	106
2017 Q4	$20.2M	Sell	144,279 -12,484	-8%	-$1.74M	0.45%	107
2017 Q3	$20.4M	Sell	156,763 -67,909	-30%	-$9M	0.46%	103
2017 Q2	$29.7M	Buy	224,672 +1,052	+0.5%	+$134K	0.61%	67
2017 Q1	$27.9M	Buy	+223,620	New	+$26.7M	0.57%	74
2016 Q1	–	Sell	-829,750	Closed	-$85.2M	–	241
2015 Q4	$85.2M	Sell	829,750 -53,240	-6%	-$5.35M	1.58%	4
2015 Q3	$82.4M	Buy	882,990 +16,590	+2%	+$1.6M	1.47%	5
2015 Q2	$84.4M	Buy	+866,400	New	+$86.8M	1.24%	9
2014 Q2	–	Sell	-701,342	Closed	-$68.9M	–	314
2014 Q1	$68.9M	Sell	701,342 -14,050	-2%	-$1.3M	0.83%	30
2013 Q4	$65.5M	Sell	715,392 -1,600	-0.2%	-$147K	0.83%	34
2013 Q3	$62.2M	Sell	716,992 -58,677	-8%	-$5.26M	0.85%	31
2013 Q2	$66.6M	Buy	+775,669	New	+$65.8M	0.91%	30

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s JNJ Position: Q1 2026 in Review

DePrince Race & Zollo Inc (DRZ) reduced its Johnson & Johnson (JNJ) stake by 0.24% in Q1 2026, selling an estimated $147K and leaving 260,858 shares worth $63.8M. The position accounts for 1.2% of the portfolio, ranked #17.

DePrince Race & Zollo Inc (DRZ) first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. The position peaked at $85.2M in Q4 2015. 4,627 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

DePrince Race & Zollo Inc (DRZ) held 260,858 shares of Johnson & Johnson worth $63.8M as of Q1 2026.
DePrince Race & Zollo Inc (DRZ) sold 630 Johnson & Johnson shares in Q1 2026, an estimated $147K.
Johnson & Johnson made up 1.2% of DePrince Race & Zollo Inc (DRZ)'s portfolio in Q1 2026, its #17 holding.
DePrince Race & Zollo Inc (DRZ) first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
DePrince Race & Zollo Inc (DRZ)'s Johnson & Johnson position peaked at $85.2M in Q4 2015.
4,627 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q1 2026, filed 24 Apr 2026.